Charles River Laboratories | CRL - Cost Of Sales


Charles River Laboratories reported $655.29M in Cost of Sales for its fiscal quarter ending in June of 2026.





Cost Of Sales Change Date
Agilent USD 836M 9M Jun/2026
Align Technology USD 298.76M 4.74M Jun/2026
Bio-Rad Laboratories USD 305.2M 22.5M Jun/2026
Bruker USD 422.5M 21.1M Jun/2026
Cardinal Health USD 61.23B 2.7B Jun/2026
Charles River Laboratories USD 655.29M 61.22M Jun/2026
Cigna USD 65.13B 2.72B Jun/2026
Concord Medical Services Hldg CNY 229.8M 24.9M Dec/2025
CVS Health USD 90.35B 5.54B Jun/2026
Danaher USD 2.65B 294M Jun/2026
Dentsply International USD 405M 48M Jun/2026
Elevance Health USD 38.07B 75M Dec/2025
Humana USD 26.54B 1.15B Mar/2025
Illumina USD 389M 19M Jun/2026
Incyte USD 104.96M 457K Jun/2026
Intrexon USD 1.01M 344K Jun/2024
IQVIA Holdings USD 3.22B 141M Jun/2026
Laboratory Of America USD 2.7B 97.8M Jun/2026
Lakefront Biotherapeutics EUR 9.14M 4.35M Jun/2026
Lonza CHF 2.28B 189M Jun/2025
McKesson USD 101.7B 9.44B Jun/2026
Merck EUR 2.27B 199M Jun/2026
Mettler Toledo International USD 396.52M 14.4M Jun/2026
Novartis USD 3.71B 251M Jun/2026
Pfizer USD 4.09B 498M Jun/2026
Quest Diagnostics USD 2.05B 64M Jun/2026
Revvity USD 312.82M 10.64M Jun/2026
Thermo Fisher Scientific USD 7.54B 577M Jun/2026
United Therapeutics USD 99.5M 33.9M Jun/2026
UnitedHealth USD 86.31B 8.41B Mar/2026
Veradigm USD 124.74M 56.25M Dec/2022
Waters USD 1.16B 430M Jun/2026
West Pharmaceutical Services USD 543.1M 5.4M Jun/2026